Teleflex Incorporated

TFX Healthcare Medical Instruments & Supplies

Teleflex Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 17.2% from fiscal 2024.

Revenue
+28.9%
EPS
−17.3%
Free cash flow
+220.1%
Total debt
+47.7%

Quarter to June 2026, against a year earlier

152.16 2.29 +1.53%
Market cap
$6.5B
P/E
0.0×
Fwd P/E
37.4×
Dividend yield
0.89%
F-score
5/9
Altman Z
2.04
Beneish M
−2.21
Dividend safety
20/100

Teleflex Incorporated (TFX) P/E ratio

Alert me on P/E ratio

Teleflex Incorporated has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 188× (December 2018) — the current reading is the lowest in ten years.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 0.0× —
FY2024 123× 271.51%
FY2023 33.0× 2.48%
FY2022 32.2× 1.78%
FY2021 31.7× (44.43%)
FY2020 57.0× 51.28%
FY2019 37.7× (36.00%)
FY2018 58.9× (21.87%)
FY2017 75.4× 159.97%
FY2016 29.0× 29.67%

Quarterly newest first

Period P/E ratio Change
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
Sep 2025 0.0× —
42 more quarters

Against its own ten years

Low 0.0× High 188×
Ten-year median 32.9×
Current reading's percentile 9

P/E ratio against peers

Company P/E ratio
PLSE Pulse Biosciences, Inc compare n/m
MMED MiniMed Group, Inc. compare n/m
BLCO Bausch + Lomb Corporation compare n/m
TFX Teleflex Incorporated n/m
NVST Envista Holdings Corporation compare 6.4×
AVTR Avantor, Inc. compare 30.3×
MMSI Merit Medical Systems, Inc. compare 33.2×
ATR AptarGroup, Inc. compare 34.6×
ICUI ICU Medical, Inc. compare 69.3×
Medical Instruments & Supplies industry median 30.3×
Healthcare sector median 25.2×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on TFX